Intellipharmaceutics International Inc. (IPCI.TO) TSX
0.08
-0.01(-11.11%)
Currency In CAD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 2.47M |
| Enterprise Value | 4.71M |
| P/E Ratio | -1.72 |
| PEG Ratio | 0.02 |
| Price/Sales Ratio | 75.52 |
| Price/Book Ratio | -0.47 |
| Enterprise/Revenue | 109.64 |
| Enterprise/EBITDA | -2.73 |
Fiscal Year
| Fiscal Year | November 30, 2022 |
| Most Recent Quarter | August 31, 2023 |
Profitability
| Profit Margin | -44.01 |
| Operating Margin | -43.37 |
Management Effectiveness
| Return On Assets | -2.02 |
| Return On Equity | 0.27 |
Income Statement
| Revenue | 65,728 |
| Revenue/Share | 0 |
| Gross Profit | 65,728 |
| EBITDA | -2.39M |
| Net Income | -2.89M |
| Diluted EPS | -0.09 |
Balance Sheet
| Total Cash | 400,102 |
| Total Cash/Share | 0 |
| Total Debt | 2.22M |
| Total Debt/Equity | -0.22 |
| Current Ratio | 0.04 |
| Book Value Per Share | -0.32 |
Price History
| 52-Week Change | 0 |
| 52-Week High | 0.17 |
| 52-Week Low | 0.04 |
| Moving Average 50 Days | 0.08 |
| Moving Average 200 Days | 0.09 |
Statistics
| Average Volume | 4,905 |
| Shares Outstanding | 33.09M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:10 |
| Last Split Date | September 14, 2018 |
